MicroVision, Inc.
9.5.2024 22:07:59 CEST | ACCESS Newswire | Press release
REDMOND, WA / ACCESSWIRE / May 9, 2024 / MicroVision, Inc. (NASDAQ:MVIS), a leader in MEMS-based solid-state automotive lidar and ADAS solutions, today announced its first quarter 2024 results.
Key Business Highlights for Q1 2024
- Actively engaged in high-volume, top-tier global OEM RFQs for passenger vehicles.
- Expanding near-term revenue opportunities through direct sales in industrial markets.
- Working to accumulate non-dilutive cash by leveraging partnerships and licensing opportunities.
- Increasing cash runway through proactive, disciplined fiscal management.
"Energized by global OEM feedback that MicroVision offers the best technical and commercial solutions, we remain confident in our engagement with automotive OEMs and our prospects in high-volume, top-tier, passenger-vehicle RFQs," said Sumit Sharma, MicroVision's Chief Executive Officer. "As we navigate current headwinds in the automotive industry and lidar sector with a healthy balance of optimism and realism, we are aggressively pursuing near-term revenue opportunities in industrial markets and with partnership opportunities, as well as continuing our ethos of fiscal discipline."
"I remain committed to steering MicroVision and firmly establishing it as a leading automotive OEM supplier of lidar hardware and software solutions," continued Sharma.
Key Financial Highlights for Q1 2024
- Revenue for the first quarter of 2024 was $1.0 million, compared to $0.8 million for the first quarter of 2023 primarily driven by sales of MOVIA sensors to a global commercial trucking OEM.
- Net loss for the first quarter of 2024 was $26.3 million, or $0.13 per share, which includes $3.7 million of non-cash, share-based compensation expense, compared to a net loss of $19.0 million, or $0.11 per share, which includes $2.9 million of non-cash, share-based compensation expense, for the first quarter of 2023.
- Adjusted EBITDA for the first quarter of 2024 was a $18.7 million loss, compared to a $15.7 million loss for the first quarter of 2023.
- Cash used in operations in the first quarter of 2024 was $20.8 million, compared to cash used in operations in the first quarter of 2023 of $13.5 million.
- The Company ended the first quarter of 2024 with $73.1 million in cash and cash equivalents including investment securities, compared to $73.8 million at December 31, 2023.
Conference Call and Webcast: Q1 2024 Results
MicroVision will host a conference call and webcast, consisting of prepared remarks by management, a slide presentation, and a question-and-answer session at 1:30 PM PT/4:30 PM ET on Thursday, May 9, 2024 to discuss the financial results and provide a business update. Analysts and investors may pose questions to management during the live webcast on May 9, 2024.
The live webcast and slide presentation can be accessed on the Company's Investor Relations website under the Events tab at https://ir.microvision.com/events. The webcast will be archived on the website for future viewing.
About MicroVision
With offices in the U.S. and Germany, MicroVision is a pioneering company in MEMS-based laser beam scanning technology that integrates MEMS, lasers, optics, hardware, algorithms and machine learning software into its proprietary technology to address existing and emerging markets. The Company's integrated approach uses its proprietary technology to provide automotive lidar sensors and solutions for advanced driver-assistance systems (ADAS) and for non-automotive applications including industrial, smart infrastructure and robotics. The Company has been leveraging its experience building augmented reality micro-display engines, interactive display modules, and consumer lidar modules.
For more information, visit the Company's website at www.microvision.com, on Facebook at www.facebook.com/microvisioninc, and LinkedIn at https://www.linkedin.com/company/microvision/.
MicroVision, MAVIN, MOSAIK, and MOVIA are trademarks of MicroVision, Inc. in the United States and other countries. All other trademarks are the properties of their respective owners.
Non-GAAP information
To supplement MicroVision's condensed financial statements presented in accordance with GAAP, the Company presents investors with the non-GAAP financial measures "adjusted EBITDA" and "adjusted Gross Profit." Adjusted EBITDA consists of GAAP net income (loss) excluding the impact of the following: interest income and interest expense; income tax expense; depreciation and amortization; bargain purchase gain; share-based compensation; and restructuring charges. Adjusted Gross Profit is calculated as GAAP gross profit before share-based compensation expense and the amortization of acquired intangibles included in cost of revenue.
MicroVision believes that the presentation of adjusted EBITDA and adjusted Gross Profit provides important supplemental information to management and investors regarding financial and business trends, provides consistency and comparability with MicroVision's past financial reports, and facilitates comparisons with other companies in the Company's industry, many of which use similar non-GAAP financial measures to supplement their GAAP results. Internally, management uses these non-GAAP measures when evaluating operating performance because the exclusion of the items described above provides an additional useful measure of the Company's operating results and facilitates comparisons of the Company's core operating performance against prior periods and its business objectives. Externally, the Company believes that adjusted EBITDA and adjusted Gross Profit are useful to investors in their assessment of MicroVision's operating performance and the valuation of the Company.
Adjusted EBITDA and adjusted Gross Profit are not calculated in accordance with GAAP, and should be considered supplemental to, and not as a substitute for, or superior to, financial measures calculated in accordance with GAAP. Non-GAAP financial measures have limitations in that they do not reflect all of the costs associated with the operations of MicroVision's business as determined in accordance with GAAP. The Company expects to continue to incur expenses similar to the non-GAAP adjustments described above, and exclusion of these items from its non-GAAP financial measures should not be construed as an inference that these costs are unusual or infrequent.
The Company compensates for limitations of the adjusted EBITDA measure by prominently disclosing GAAP net income (loss), which the Company believes is the most directly comparable GAAP measure, and providing investors with a reconciliation from GAAP net income (loss) to adjusted EBITDA.
Similarly for Adjusted Gross Profit, the Company compensates for limitations of the measure by prominently disclosing GAAP gross profit which is the difference between Revenue and Cost of revenue, which the Company believes is the most directly comparable GAAP measure, and providing investors with a reconciliation by backing out share-based compensation expense and the amortization of acquired intangibles included in cost of revenue.
Forward-Looking Statements
Certain statements contained in this release, including customer engagement and the likelihood of success, opportunities for revenue and cash, expense reduction, market position, product portfolio, product and manufacturing capabilities, and expected revenue, expenses and cash usage are forward-looking statements that involve a number of risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. Factors that could cause actual results to differ materially from those projected in such forward-looking statements include the risk its ability to operate with limited cash or to raise additional capital when needed; market acceptance of its technologies and products or for products incorporating its technologies; the failure of its commercial partners to perform as expected under its agreements; its financial and technical resources relative to those of its competitors; its ability to keep up with rapid technological change; government regulation of its technologies; its ability to enforce its intellectual property rights and protect its proprietary technologies; the ability to obtain customers and develop partnership opportunities; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market its products; potential product liability claims; its ability to maintain its listing on The Nasdaq Stock Market, and other risk factors identified from time to time in the Company's SEC reports, including the Company's Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and other reports filed with the SEC. These factors are not intended to represent a complete list of the general or specific factors that may affect the Company. It should be recognized that other factors, including general economic factors and business strategies, may be significant, now or in the future, and the factors set forth in this release may affect the Company to a greater extent than indicated. Except as expressly required by federal securities laws, the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.
Investor Relations Contact
Jeff Christensen
Darrow Associates Investor Relations
MVIS@darrowir.com
Media Contact
Microvision, Inc.
Consolidated Balance Sheet
(In thousands)
(Unaudited)
| March 31, | December 31, | |||||||
| 2024 | 2023 | |||||||
Assets | ||||||||
Current Assets | ||||||||
Cash and cash equivalents | $ | 44,298 | $ | 45,167 | ||||
Investment securities, available-for-sale | 28,770 | 28,611 | ||||||
Restricted cash, current | 71 | 3,263 | ||||||
Accounts receivable, net of allowances | 1,121 | 949 | ||||||
Inventory | 3,738 | 3,874 | ||||||
Other current assets | 4,302 | 4,890 | ||||||
Total current assets | 82,300 | 86,754 | ||||||
Property and equipment, net | 8,549 | 9,032 | ||||||
Operating lease right-of-us asset | 13,212 | 13,758 | ||||||
Restricted cash, net of current portion | 1,968 | 961 | ||||||
Intangible assets, net | 16,662 | 17,235 | ||||||
Other assets | 1,491 | 1,895 | ||||||
Total assets | $ | 124,182 | $ | 129,635 | ||||
Liabilities and Shareholders' Equity | ||||||||
Current Liabilities | ||||||||
Accounts payable | $ | 2,161 | $ | 2,271 | ||||
Accrued liabilities | 9,971 | 8,640 | ||||||
Accrued liability for Ibeo business combination | 2,969 | 6,300 | ||||||
Contract liabilities | 213 | 300 | ||||||
Current portion of operating lease liability | 2,167 | 2,323 | ||||||
Other current liabilities | 270 | 669 | ||||||
Total current liabilities | 17,751 | 20,503 | ||||||
Operating lease liability, net of current portion | 12,358 | 12,714 | ||||||
Other long-term liabilities | 270 | 614 | ||||||
Total liabilities | 30,379 | 33,831 | ||||||
Commitments and contingencies | ||||||||
Shareholders' Equity | ||||||||
Common stock at par value | 206 | 195 | ||||||
Additional paid-in capital | 885,119 | 860,765 | ||||||
Accumulated other comprehensive loss | 157 | 210 | ||||||
Accumulated deficit | (791,679 | ) | (765,366 | ) | ||||
Total shareholders' equity | 93,803 | 95,804 | ||||||
Total liabilities and shareholders' equity | $ | 124,182 | $ | 129,635 | ||||
MicroVision, Inc.
Consolidated Statement of Operations
(In thousands, except earnings per share data)
(Unaudited)
| Three months ended March 31, | ||||||||
| 2024 | 2023 | |||||||
Revenue | $ | 956 | $ | 782 | ||||
Cost of revenue | 1,277 | 544 | ||||||
Gross profit | (321 | ) | 238 | |||||
Research and development expense | 17,311 | 12,692 | ||||||
Sales, marketing, general and administrative expense | 9,078 | 8,737 | ||||||
Total operating expenses | 26,389 | 21,429 | ||||||
Loss from operations | (26,710 | ) | (21,191 | ) | ||||
Bargain purchase gain | - | 1,706 | ||||||
Other income, net | 631 | 639 | ||||||
Net loss before taxes | $ | (26,079 | ) | $ | (18,846 | ) | ||
Income tax expense | (234 | ) | (181 | ) | ||||
Net income (loss) | $ | (26,313 | ) | $ | (19,027 | ) | ||
Net income (loss) per share - basic and diluted | $ | (0.13 | ) | $ | (0.11 | ) | ||
Weighted-average shares outstanding - basic and diluted | 196,748 | 174,703 | ||||||
Microvision, Inc.
Consolidated Statement of Cash Flows
(In thousands)
(Unaudited)
| Three months ended March 31, | ||||||||
| 2024 | 2023 | |||||||
Cash flows from operating activities | ||||||||
Net loss | $ | (26,313 | ) | $ | (19,027 | ) | ||
Adjustments to reconcile net loss to | ||||||||
net cash used in operations | ||||||||
Depreciation and amortization | 1,800 | 2,524 | ||||||
Impairment of property and equipment | 13 | - | ||||||
Bargain purchase gain | - | (1,706 | ) | |||||
Share-based compensation expense | 3,743 | 2,949 | ||||||
Inventory write-down | 9 | 29 | ||||||
Net accretion of premium on short-term investments | (288 | ) | (396 | ) | ||||
Change in: | ||||||||
Accounts receivable | (172 | ) | (506 | ) | ||||
Contract assets | - | (192 | ) | |||||
Inventory | 102 | (87 | ) | |||||
Other current and non-current assets | 992 | 647 | ||||||
Accounts payable | (527 | ) | 1,629 | |||||
Accrued liabilities | 1,331 | 2,017 | ||||||
Contract liabilities and other current liabilities | (480 | ) | (711 | ) | ||||
Operating lease liabilities | (639 | ) | (669 | ) | ||||
Other long-term liabilities | (330 | ) | 17 | |||||
Net cash used in operating activities | (20,759 | ) | (13,482 | ) | ||||
Cash flows from investing activities | ||||||||
Sales of investment securities | 7,900 | 22,000 | ||||||
Purchases of investment securities | (7,805 | ) | (3,898 | ) | ||||
Purchases of property and equipment | (114 | ) | (615 | ) | ||||
Cash paid for Ibeo business combination | (3,263 | ) | (11,233 | ) | ||||
Net cash provided by (used in) investing activities | (3,282 | ) | 6,254 | |||||
Cash flows from financing activities | ||||||||
Principal payments under finance leases | - | (6 | ) | |||||
Proceeds from stock option exercises | 62 | - | ||||||
Net proceeds from issuance of common stock | 20,956 | 12,691 | ||||||
Net cash provided by financing activities | 21,018 | 12,685 | ||||||
Effect of exchange rate changes on cash and cash equivalents | (31 | ) | - | |||||
Net increase (decrease) in cash and cash equivalents | (3,054 | ) | 5,457 | |||||
Cash, cash equivalents and restricted cash at beginning of period | 49,391 | 21,954 | ||||||
Cash, cash equivalents and restricted cash at end of period | $ | 46,337 | $ | 27,411 | ||||
| The following table provides a reconciliation of the cash, cash equivalents, and restricted cash balances as of | ||||||||
March 31, 2024 and December 31, 2023: | ||||||||
| March 31, | December 31, | |||||||
| 2024 | 2023 | |||||||
Cash and cash equivalents | $ | 44,298 | $ | 45,167 | ||||
Restricted cash | 2,039 | 4,224 | ||||||
Cash, cash equivalents and restricted cash | 46,337 | 49,391 | ||||||
MicroVision, Inc.
Reconciliation of GAAP to Non-GAAP Measures
(In thousands, except earnings per share data)
(Unaudited)
| Three months ended March 31, | ||||||||
| 2024 | 2023 | |||||||
Reconciliation of Non-GAAP Gross Profit: | ||||||||
Gross Profit | $ | (321 | ) | $ | 238 | |||
Share-based compensation expense | - | - | ||||||
Amortization of acquired intangibles | 387 | 255 | ||||||
Adjusted Gross Profit | $ | 66 | $ | 493 | ||||
Reconciliation of Non-GAAP Loss: | ||||||||
GAAP Net loss | $ | (26,313 | ) | $ | (19,027 | ) | ||
Other Income/Expense,net | (631 | ) | (639 | ) | ||||
Income taxes | 234 | 181 | ||||||
Depreciation & amortization | 1,800 | 2,524 | ||||||
Bargain purchase gain | - | (1,706 | ) | |||||
Share-based compensation expense | 3,743 | 2,949 | ||||||
Restructuring costs | 2,474 | - | ||||||
Adjusted EBITDA | $ | (18,693 | ) | $ | (15,718 | ) | ||
SOURCE: MicroVision, Inc.
View the original press release on accesswire.com
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
AI Trading Changing Stock, Gold, and Forex Trading Market: Funds Coin's Multi-Agent Trading Update Dominates20.5.2026 11:00:00 CEST | Press release
DENVER, CO / ACCESS Newswire / May 20, 2026 / Ten years ago, algorithmic trading was the exclusive territory of investment banks and hedge funds. Today, a retail trader with $100 and a smartphone can access the same class of automated execution that once required a team of quants and millions in infrastructure. That's not an exaggeration. It's the shift that's quietly reshaping stock and forex markets, and AI trading agents are at the center of it. The Old Way Is Breaking Down Manual trading made sense when markets moved slowly enough for humans to keep up. That world no longer exists. Forex markets process over $7 trillion in daily volume. Crypto trades around the clock across hundreds of exchanges. Stock prices react to news in milliseconds. The information moves faster than any individual trader can process, and emotions, such as fear, greed, and hesitation, make an already difficult job even harder. The traders who thrived in this environment were either exceptionally disciplined o
Karbon-X and Evertrak Sign Letter of Intent to Advance Infrastructure-Linked Plastic Waste Reduction Credit Initiative19.5.2026 19:45:00 CEST | Press release
Proposed initiative would evaluate the potential generation of Verra-aligned Plastic Waste Reduction Credits for approximately 200,000 railroad ties made from recycled plastic currently installed across railroad infrastructure in North America. CALGARY, AB / ACCESS Newswire / May 19, 2026 / Karbon-X Corp. (OTCQB:KARX) ("Karbon-X" or the "Company"), a vertically integrated climate solutions company operating across compliance and voluntary environmental markets, today announced the signing of a Letter of Intent with Evertrak LLC ("Evertrak"), the leading manufacturer of Glass Fiber Reinforced Composite (GFRC) railroad ties made from recycled plastic, to explore an infrastructure-linked Plastic Waste Reduction Credit ("PWRC") initiative under Verra's Plastic Waste Reduction (PWR) Standard. Across North America, 20 million railroad ties made from wood are replaced annually. Approximately 4-6 million of those ties are less than 12 years old. Safe, resilient, and efficient railroad infrastr
AP Technologies Acquires Blueacre Technology, Adding Nitinol and Precision Laser Processing to Its Catheter Platform19.5.2026 16:00:00 CEST | Press release
Acquisition extends AP Technologies' vertically integrated catheter platform into nitinol and precision laser processing. Dundalk, Ireland joins the company's network of Centers of Excellence as its first European operation. SINGAPORE AND DUNDALK, IRELAND / ACCESS Newswire / May 19, 2026 / AP Technologies, a vertically integrated contract manufacturer of catheters and medical tubing, today announced the acquisition of Blueacre Technology, a Dundalk, Ireland specialist in laser micromachining and nitinol processing for the medical device industry. The acquisition establishes AP Technologies' first European operation in Ireland's medtech corridor, and extends its catheter platform into the laser-processed metallic components used in next-generation minimally invasive devices. Terms were not disclosed. Blueacre brings nearly two decades of capability in laser micromachining and nitinol processing for the medical device industry, including femtosecond and picosecond laser cutting, laser we
Business Leaders Still Primarily Use AI for Simple Tasks, Study from General Assembly and EZRA Finds19.5.2026 15:00:00 CEST | Press release
Those who have received leadership-specific AI training more likely to use AI more often and more strategically NEW YORK CITY, NY / ACCESS Newswire / May 19, 2026 / A new survey of more than 500 U.S. and U.K. business leaders found that while they are increasingly confident in their own AI skills, the most common use cases of the technology at the leadership level remain simple tasks like searching for information (69%), summarizing documents (68%) and drafting emails (58%). Strategic applications such as scenario planning (27%), organizational design (27%) and financial modeling (28%) lag far behind. The research was conducted by General Assembly, a global leader in practical AI skills training, in collaboration with EZRA, a leading global coaching and learning provider, both LHH brands. The study also surfaces a sharp divide between leadership levels. Vice presidents consistently fall behind director-level colleagues across nearly every measure of AI adoption and competence, emerging
Europe's Hospital Cybersecurity Hot Zones and Top Cyber Vendors as EHR and EPR Attacks Shift From Data Theft to Care Disruption19.5.2026 14:50:00 CEST | Press release
Recent European hospital incidents, NIS2 accountability, EPR exposure, supplier concentration, and 72-hour downtime weakness are pushing buyers toward clinical-continuity cybersecurity ahead of HIMSS26 Europe COPENHAGEN, DK / ACCESS Newswire / May 19, 2026 / Black Book Research today issued a new European hospital cybersecurity advisory identifying the countries, attack surfaces, vendor categories, and evaluation standards now shaping hospital cybersecurity buying decisions across Europe. The advisory builds on Black Book's Pre-HIMSS26 Europe Copenhagen Cybersecurity Demand Pulse Survey of 284 self-identified European hospital, health system, HIT, clinical-digital, cybersecurity, procurement, risk, and executive respondents seeking cybersecurity options around HIMSS26 Europe in Copenhagen. Black Book reports that European hospital cybersecurity has moved beyond breach response. The 2026 priority is now clinical availability: protecting EHRs, EPRs, identity systems, lab platforms, pharm
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
